Tumor-Cell Number and Viability as Quality and Efficacy Parameters of Autologous Virus-Modified Cancer Vaccines in Patients With Breast or Ovarian Cancer
Authors:
- T. AhlertTAT. Ahlert
- W. SauerbreiWSW. Sauerbrei
- G. BastertGBG. Bastert
- S. RuhlandSRS. Ruhland
- B. BartikBBB. Bartik
- N. SimiantonakiNSN. Simiantonaki
- J. SchumacherJSJ. Schumacher
- B. HackerBHB. Hacker
- M. SchumacherMSM. Schumacher
- V. SchirrmacherVSV. Schirrmacher
- 1 July 1997
- journal article
- correction
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 15 (7) , 2763